Asthma affects millions of people across the country, including over 4 million kids. Using asthma medicines correctly is ...

Please provide your email address to receive an email when new articles are posted on . Bifidobacterium infantis 35624 can decrease levels of dysfunctional T regulatory cells. There were no ...

An asthma self-management app paired with wearables improved asthma control for adults in a randomized controlled trial. African American patients gained less from the digital intervention. The study ...

The digital asthma self-management program significantly improved symptom control, especially for those with uncontrolled asthma, showing a 2.8-point Asthma Control Test score difference over usual ...

Please provide your email address to receive an email when new articles are posted on . HbA1c results ranged from 4.2% to 6.1% among children with asthma. 28 of 128 children with asthma had HbA1c at ...

In adults with asthma, a digital asthma self-management (DASM) program improved symptom control compared with usual care, although its effectiveness varied by race, with weaker results observed among ...

Not all children and teens with active asthma are achieving adequate control of their symptoms, and timely referral to secondary care is rare, according to one study. There is a prevalence of poorly ...

(Salt Lake City) - An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease. When families monitored symptoms with eAsthma Tracker and adjusted care ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.